Despite advances in treatment for high cholesterol, heart disease remains the leading cause of death in the U.S. Scientists at the Medical College of Wisconsin (MCW) are investigating the role of a form of cholesterol called very-low-density lipoprotein – and their findings may lead to new treatment options in the future.
When treating Alzheimer’s, earlier is better, according to analysis of Lilly and Eisai trials
The drugmakers behind the new class of Alzheimer’s treatments are coalescing around a common narrative: when it comes to slowing the disease, the earlier a